Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NP001 in mild-to-moderate Alzheimer's disease
NCT03179501Phase 1Terminated
- Sponsor
- Beau Nakamoto
- Start
- Sep 2017
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sodium chlorite in Alzheimer's disease (AD), sponsored by Beau Nakamoto. Started Sep 2017; status: terminated.
02
Drugs
sodium chlorite
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03179501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03179501.